Brief report: Childhood-onset systemic necrotizing vasculitides: Long-term data from the French vasculitis study group registry

Arthritis and Rheumatology

Volumn 67, Issue 7, 2015, Pages 1959-1965

  Iudici, Michele ^a,n   Puéchal, Xavier ^a   Pagnoux, Christian ^b   Quartier, Pierre ^c   Agard, Christian ^d   Aouba, Achille ^e   Büchler, Matthias ^f   Cevallos, Ramiro ^g   Cohen, Pascal ^a   De Moreuil, Claire ^h   Guilpain, Philippe ⁱ   Le Quellec, Alain ⁱ   Roblot, Pascal ^j   Serratrice, Jacques ^k   Bachmeyer, Claude ^l   Daugas, Éric ^m   Terrier, Benjamin ^a   Mouthon, Luc ^a   Guillevin, Loïc ^a  

^a Institut Cochin   (France)

^b MOUNT SINAI HOSPITAL   (Canada)

^c IMAGINE INSTITUTE   (France)

^d HÔTEL DIEU   (France)

^e CAEN UNIVERSITY HOSPITAL   (France)

^f CHU BRETONNEAU   (France)

^g Service des urgences   (France)

^h SERVICE DE RHUMATOLOGIE   (France)

ⁱ HÔPITAL SAINT ELOI   (France)

^j POITIERS UNIVERSITY HOSPITAL   (France)

^k TIMONE HOSPITAL   (France)

^l HÔPITAL TENON   (France)

^m BICHAT HOSPITAL   (France)

ⁿ SECOND UNIVERSITY OF NAPLES   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD ONSET SYSTEMIC NECROTIZING VASCULITIDES; CHURG STRAUSS SYNDROME; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEATH; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; COMPARATIVE STUDY; FRANCE; INCIDENCE; LONGITUDINAL STUDY; MORTALITY; ONSET AGE; POLYARTERITIS NODOSA; PRESCHOOL CHILD; PROGNOSIS; RECURRENT DISEASE; REGISTER; SURVIVAL RATE;

ADOLESCENT; AGE OF ONSET; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; POLYARTERITIS NODOSA; PROGNOSIS; RECURRENCE; REGISTRIES; SURVIVAL RATE; SYSTEMIC VASCULITIS;

EID: 84933056550     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39122     Document Type: Article

References (19)

1. Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, et al., Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 1993; 122: 26-31.
2. Stegmayr BG, Gothefors L, Malmer B, Muller Wiefel DE, Nilsson K, Sundelin B., Wegener granulomatosis in children and young adults: a case study of ten patients. Pediatr Nephrol 2000; 14: 208-13.
3. Hattori M, Kurayama H, Koitabashi Y, and members and co-workers of the Japanese Society for Pediatric Nephrology. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol 2001; 12: 1493-500.
4. Belostotsky VM, Shah V, Dillon MJ., Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 2002; 17: 754-61.
5. Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, et al., Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum 2007; 57: 837-44.
6. Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G, et al, for the ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators Network. Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum 2009; 60: 3413-24.
7. Bakkaloglu A, Ozen S, Baskin E, Besbas N, Gur-Guven A, Kasapcopur O, et al., The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa. Arch Dis Child 2001; 85: 427-30.
8. Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, et al., Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 2004; 145: 517-22.
9. Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ, et al., Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum 2013; 65: 2476-85.
10. Falcini F, La Torre F, Vittadello F, Rigante D, Martini G, Corona F, et al., Clinical overview and outcome in a cohort of children with polyarteritis nodosa. Clin Exp Rheumatol 2014; 32 Suppl 82: S134-7.
11. Zwerina J, Eger G, Englbrecht M, Manger B, Schett G., Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients. Semin Arthritis Rheum 2009; 39: 108-15.
12. Gendelman S, Zeft A, Spalding SJ., Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort. J Rheumatol 2013; 40: 929-35.
13. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al., The American College of Rheumatology 1990 criteria for the classification of vasculitis: introduction. Arthritis Rheum 1990; 33: 1065-7.
14. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al, for the Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II. Final classification criteria. Ann Rheum Dis 2010; 69: 798-806.
15. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al., 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65: 1-11.
16. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al., Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 671-8.
17. Dolezalova P, Price-Kuehne FE, Ozen S, Benseler SM, Cabral DA, Anton J, et al., Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis 2013; 72: 1628-33.
18. Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, et al., EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007; 66: 605-17.
19. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al., Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997; 40: 371-80.